Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in AXGN — Axogen, Inc.

CIK 1009207 New York, NY
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,828,718
+$4,048,970 QoQ
Shares Held
277,738
+4.8% QoQ
Ownership
0.517%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 253 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,449,763,142 across 60 Medical Devices names. AXGN ranks #17 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 25,457,409 $1,086,522,216
2 MDT
Medtronic plc
 4,396,781 $343,960,176
3 ABT
Abbott Laboratories
 1,457,592 $132,261,897
4 STE
STERIS plc
 509,610 $107,308,577
5 BRKR
Bruker Corp
 340,853 $99,997,183
6 SYK
Stryker Corp
 270,554 $85,181,220
7 IRTC
iRhythm Holdings, Inc.
 629,686 $74,901,149
8 INSP
Inspire Medical Systems, Inc.
 1,470,462 $65,597,309

All Filings in AXGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,828,718 277,738
2026-03-31 $8,779,748 265,009
2025-12-31 $5,264,685 160,852
2025-09-30 $3,106,728 174,144
2025-06-30 $4,865,498 448,433
2025-03-31 $10,404,881 562,426
2024-12-31 $8,047,282 488,306
2024-09-30 $8,893,502 634,344
2024-06-30 $4,406,155 608,585
2024-03-31 $4,894,898 606,555
2023-12-31 $4,173,048 610,988
2023-09-30 $2,877,225 575,445
2023-06-30 $6,526,142 714,802
2023-03-31 $6,371,076 674,188
2022-12-31 $7,082,776 709,697
2022-09-30 $7,841,417 657,837
2022-06-30 $6,031,116 736,400
2022-03-31 $6,418,624 808,391
2021-12-31 $7,403,320 790,109
2021-09-30 $9,636,799 609,924
2021-06-30 $12,939,311 598,765
2021-03-31 $12,411,924 612,632
2020-12-31 $11,755,753 656,746
2020-09-30 $8,796,222 756,339
2020-06-30 $7,024,525 760,230
2020-03-31 $7,422,906 713,741